Clinical-Microbiomics A/S — Credit Rating and Financial Key Figures

Clinical-Microbiomics A/S (CVR number: 37230634K) is a company from KØBENHAVN. The company recorded a gross profit of 6221 kEUR in 2023. The operating profit was -2313 kEUR, while net earnings were -2542 kEUR. The profitability of the company measured by Return on Assets (ROA) was -3.7 %, which can be considered poor and Return on Equity (ROE) was -5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 82.9 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Clinical-Microbiomics A/S's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.